- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose(Non-covalent)
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pennington, L.F. et al., Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex. Nat Commun (2021)
- Release Date
- 2021-12-15
- Peptides
- IgE Fc: AD
813 Variable fragment Heavy chain: BE
813 Variable fragment Light chain: CF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
AB
EE
CC
FF
D